CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Eloxx Pharmaceuticals, Inc.

ELOX
$64MMicro Cap

Next catalyst

Phase 2Q2 2027

Exaluren

Alport Syndrome, X-Linked

Get an email about ELOX's next catalysts

Track Eloxx Pharmaceuticals (ELOX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (earnings).See the timeline

Catalyst Timeline

2 upcoming, 0 past

Earnings

ELOX Earnings Report

November 2026~

Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd

Phase 2Next

Exaluren Phase 2 Est. Readout

Q2 2027~QExaluren24

Estimated primary completion for Exaluren trial (NCT07523581) in Alport Syndrome, X-Linked. Topline data typically follows completion by weeks to months.

Source

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaARLINGTON
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Eloxx Pharmaceuticals, Inc.'s drug pipeline?β†’

CatalystAlert tracks 3 drug candidates in Eloxx Pharmaceuticals, Inc.'s (ELOX) pipeline across Phase 2. Its lead program is Exaluren (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Eloxx Pharmaceuticals, Inc.'s next FDA catalyst?β†’

Eloxx Pharmaceuticals, Inc.'s (ELOX) next tracked catalyst is a Phase 2 readout expected Q2 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ELOX biotech catalysts?β†’

Add ELOX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Eloxx Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply